Assertio Therapeutics Stock Price - ASRT

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Assertio Therapeutics Inc ASRT NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.3291 -28.13% 0.8409 0.8785 0.7131 0.80 1.17 17:05:21
Bid Price Ask Price Spread Spread % News
0.85 0.8744 0.0244 2.79% 1 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
8,133 4,562,912 $ 0.8175008 $ 3,730,184 1,267,219 0.7131 - 5.881
Last Trade Time Type Quantity Stock Price Currency
16:51:17 12 $ 0.84 USD

Assertio Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 67.80M 80.63M $ 36.91M 0.44 -0.66 77.42M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 9.00 4.00%

more financials information »

Assertio Therapeutics News

Loading Messages....

Latest ASRT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ASRT Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week1.251.280.71311.12682M-0.4091-32.73%
1 Month1.391.490.71311.24461M-0.5491-39.50%
3 Months3.133.550.71311.50701M-2.2891-73.13%
6 Months4.274.920.71312.19541M-3.4291-80.31%
1 Year5.735.8810.71313.2310897k-4.8891-85.32%
3 Years7.38.080.71313.5841852k-6.4591-88.48%
5 Years7.38.080.71313.5841852k-6.4591-88.48%

Assertio Therapeutics Description

Assertio Therapeutics Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid filled capsules for relief of mild to moderate pain.


Your Recent History
NASDAQ
ASRT
Assertio T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.